NEW YORK (GenomeWeb News) - Primera Biosystems said this week that it has raised $21 million in series B financing that it will use to develop diagnostic instrument and reagent kits for clinical research.
 
The funding round was led by Abingworth and included investments from Interwest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Company, and the Invus Group.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.